论文部分内容阅读
近些年来,国内外已有众多学者开展了阻断乙型肝炎(乙肝)母婴传播的临床性研究,联合应用乙肝疫苗和乙肝免疫球蛋白来提高乙肝病毒母婴阻断的结论达成共识,如湖北郭燕〔1〕、山西阎娟娟〔2〕、深圳赵捷〔3〕和上海黎健〔4〕等人的报道。连云港市卫生局和连云港市妇幼保健院为了更好地实施预防乙肝母婴传播项目,通过连云港市妇幼保健综合管理平台创建母婴阻断系统模块,全程监督管理乙肝免疫球蛋白的药品发放和使用情况,搭建绩效考核和满意度调查的可操作平台,应用信息系统达到高效、快捷、准
In recent years, many scholars at home and abroad have carried out clinical research to block the transmission of hepatitis B (HBV) from mother to infant, and reached a consensus on the combination of hepatitis B vaccine and hepatitis B immunoglobulin to improve the blocking of hepatitis B virus (HBV) Such as Hubei Guo Yan 〔1〕, Shanxi Yan Juanjuan 〔2〕, Shenzhen Zhao Jie 〔3〕 and Shanghai Li Jian 〔4〕 others reported. Lianyungang Municipal Health Bureau and Lianyungang City Maternal and Child Health Hospital in order to better implement the project of preventing mother-to-child transmission of hepatitis B, through the Lianyungang MCH management platform to create a maternal and child block system module, the whole process of supervision and management of hepatitis B immunoglobulin drug distribution and use Situation, set up an operational performance appraisal and satisfaction survey platform, the application of information systems to achieve efficient, fast, accurate